Posted in | News | Solar Energy

Nano Terra Establishes Microline PV to Commercialize Solar Photovoltaic Technology

US Equity Holdings and technology development company Nano Terra, Inc. today announced the formation of Microline PV LLC, which will develop and commercialize solar photovoltaic (PV) technology.

Developed by Nano Terra, Microline PV's metallization technology will bring significant performance improvements to crystalline silicon PV cells. Microline PV's new technology can be used directly in equipment that is already deployed in nearly every crystalline silicon PV manufacturing facility today. Moreover, the technology is compatible with the most commonly used silver pastes, a key component in the fabrication of PV cells.

"Our initial tests demonstrate the potential for Microline PV's technology to provide a dramatic increase in cell performance while requiring no capital investment in new equipment," said Greg Knight, President of Microline PV. "We are confident that this technology will provide a very substantial increase in cell efficiency and a decrease in cost per watt, which will lead to rapid industry-wide adoption."

Myer Berlow, CEO of Nano Terra, said, "We are thrilled to be partnering with US Equity Holdings to launch this exciting new venture. They have a proven track record in the PV industry, are well capitalized and have considerable experience in bringing game-changing products and technologies like ours to market quickly and successfully."

"Microline PV represents a deepening of our commitment to world-class technologies that have a potentially disruptive impact in renewable energy," said Chester Aldridge, Chairman of US Equity Holdings.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.